SCHEMBL28830140

SCHEMBL28830140

CC(=CC=O)c1ccccc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
NPC1 O15118 1/20 0.47
KDM4E B2RXH2 6/20 0.45
HPGD P15428 6/20 0.45
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
HMGB1 P09429 1/20 0.45
CA4 P22748 1/20 0.45
CA6 P23280 1/20 0.45
CA7 P43166 1/20 0.45
CA9 Q16790 1/20 0.45
NAPRT Q6XQN6 1/20 0.45
CA14 Q9ULX7 1/20 0.45
LMNA P02545 3/20 0.44
TSHR P16473 2/20 0.44
MAPT P10636 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28843621 1.00 MEN1 (0.47) MEN1KMT2ANPC1KDM4EHPGD
SCHEMBL20942903 0.79 SMN1; SMN2 (0.41) NPC1HPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL20942904 0.79 SMN1; SMN2 (0.41) NPC1HPGDALDH1A1SMN1; SMN2TSHR
SCHEMBL3421548 0.78 KMT2A (0.54) MEN1KMT2ANPC1KDM4EHPGD
SCHEMBL4366146 0.78 KMT2A (0.54) MEN1KMT2ANPC1KDM4EHPGD
SCHEMBL10433550 0.78 KMT2A (0.54) MEN1KMT2ANPC1KDM4EHPGD
SCHEMBL15705122 0.78 CES2 (0.48) MEN1KMT2ANPC1HPGDALDH1A1
SCHEMBL21148116 0.78 KMT2A (0.45) MEN1KMT2ANPC1KDM4EHPGD
SCHEMBL11744885 0.78 CES2 (0.48) MEN1KMT2AHPGDALDH1A1TSHR
SCHEMBL10433489 0.75 TSHR (0.48) MEN1KMT2ANPC1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105611923-B Sodium channel modulators for the treatment of pain and diabetes 卓莫赛尔公司 2019-08-23 CN disclosed
CN-105611923-A Sodium channel modulators for the treatment of pain and diabetes CHROMOCELL CORP 2016-05-25 CN disclosed